NOTION-2: TAVI vs. SAVR in younger low-risk patients with severe tricuspid/bicuspid aortic stenosis

NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valvesПодробнее

Short-term data from NOTION-2: TAVR vs SAVI for younger patients with aortic stenosis - EuroPCR 2024Подробнее

How should we treat low risk patients with aortic stenosis? - WebinarПодробнее

Planning for a long run: life-time management of bioprosthetic valve implantation - EuroPCR 2021Подробнее

NOTION 3: PCI in patients undergoing transcatheter aortic valve implantation - ESC 2024Подробнее

TAVI in Low Risk Patients - Prof Ravinay BhindiПодробнее

Will TAVR Replace Low Risk SAVR? (Debate 2)Подробнее

View from the Thoraxcenter: What's Hot at EuroPCR 24?Подробнее

Workshop 2 Aortic stenosis in the elderly: TAVI or surgeryПодробнее

APSC Journal Club - TAVI for severe aortic stenosis: Insights from latest trialsПодробнее

[TCTAP 2023] TCTAP Workshops - Evolution of Valve Intervention (TAVR, Mitral, Tricuspid)Подробнее

D. Angouras | Most Bicuspid aortic valves will remain in the surgical domain!Подробнее

NOTION 10 years - The Nordic Aortic Valve Intervention Trial - #ESCcongress 2023Подробнее

Transcatheter Aortic Valve Implantation (TAVI)Подробнее

How should Heart Teams adapt to recently-updated valvular heart disease guidelines? - WebinarПодробнее

Assessment & Management of Aortic Valve DiseaseПодробнее

A NOTION of Things to Come in TAVRПодробнее

ESC TV at ACC.18 - Five-Year Outcomes From NOTION TrialПодробнее

Lifetime management of patients with severe aortic stenosis - PCR London Valves 2021Подробнее